Benitec Biopharma Price Target Raised to $24.33
Benitec Biopharma Inc. has had its 12-month price target raised to $24.33, which implies an upside of 171%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Benitec Biopharma Inc. has had its 12-month price target raised to $24.33, which implies an upside of 171%.